Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve the unaudited financial ....
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has informed the exchanges that its Board of Directors will meet on Friday, November 7, 2025 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025. The trading window for designated persons remains closed from September 16, 2025 to November 9, 2025 in line with insider trading regulations. This is a standard regulatory intimation filed ahead of the upcoming earnings announcement. No financial figures have been disclosed at this stage.
No immediate impact on the stock from this filing — it is a routine procedural announcement. Investors should watch the November 7 results for actual Q2FY26/H1FY26 performance cues.